Related Experiment Video

Updated: Aug 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins and hypertension

Michel Pelat1, J-L Balligand

  • 1Unit of Pharmacology and Therapeutics, FATH 5349/Catholic University of Louvain, 53 Avenue Mounier, 1200 Brussels, Belgium.

Seminars in Vascular Medicine
|April 30, 2005
PubMed

Insights

Statins may lower blood pressure through mechanisms beyond lipid reduction, potentially improving cardiovascular outcomes. This review explores direct effects on blood pressure regulation and associated molecular pathways.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypertension and dyslipidemia are key cardiovascular disease risk factors.
  • Statins effectively lower cholesterol, reducing cardiovascular morbidity and mortality.
  • Statins also exhibit blood pressure-lowering effects, contributing to cardiovascular risk reduction.

Purpose of the Study:

  • To review the evidence that statins' cardiovascular benefits may stem from direct blood pressure-lowering effects.
  • To explore potential molecular mechanisms underlying statins' impact on blood pressure regulation.
  • To consider the implications for tailoring treatments in high-risk patients.

Main Methods:

  • Literature review of studies on statins, blood pressure, and cardiovascular disease.
  • Examination of proposed molecular mechanisms, including pleiotropic effects.
  • Analysis of effects on blood pressure homeostasis and target organ damage.

Main Results:

  • Statins may reduce blood pressure through mechanisms independent of lipid lowering.
  • Potential mechanisms include effects on endothelial function, oxidative stress, and inflammation.
  • Statins may influence central and peripheral blood pressure control.

Conclusions:

  • Statins' beneficial cardiovascular effects might be partly due to direct blood pressure regulation.
  • Further research into these mechanisms could refine treatment strategies for high-cardiovascular risk patients.
  • Effects on blood pressure and heart rate variability offer new therapeutic perspectives.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...